The FY20 HRRP FRA mechanism is intended to support promising research that will accelerate drug discovery and therapeutic development for hearing restoration or accelerate advances in the assessment, diagnosis, and treatment of auditory dysfunction.
The proposed research must be relevant to
credit:
active duty Service members, Veterans, military beneficiaries, and/or the American public.
Applications involving multidisciplinary collaborations among academia, industry, the military Services, the VA, and other Federal Government agencies are highly encouraged.